Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–activity studies (2008)
Sequence: (R-Acy-R)4AcyB
| Experiment Id | EXP000874 |
|---|---|
| Paper | Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–activity studies |
| Peptide | compound 7 |
| Delivery Success Class | no |
| In Vivo Flag | no |
| Uptake Confirmed | yes |
| Label Confidence | High |
| In Vitro Functional Effect | yes |
| Endosomal Escape Evidence | |
| Peptide Concentration | 1 µM (conjugate) |
| Rna Concentration | 1 µM (conjugate) |
| Mixing Ratio | |
| Formulation Format | covalent peptide–PMO conjugate |
| Formulation Components | |
| Size Nm | |
| Zeta Mv | |
| Model Scope | in_vitro |
| Model Type | in vitro |
| Cell Lines Or Primary Cells | HeLa pLuc705 cells |
| Animal Model | |
| Administration Route | |
| Output Type | splice correction (luciferase assay, RLU/µg protein) |
| Output Value | |
| Output Units | |
| Output Notes | Splice correction at 1 µM; see Fig.1C. Uptake quantified by FACS; see Fig.4. |
| Toxicity Notes | Concentration-dependent membrane destabilization observed (PI uptake) up to 2.5 µM; see text around Fig.4B. |
| Curation Notes |